Sign In
Buy NARI
$79.97
+0 (+0%)
At Close: May 16, 2025
Inari Medical (NARI) Posts Positive Results of FLASH Registry
01:33pm, Tuesday, 20'th Sep 2022
Inari Medical's (NARI) FlowTriever's latest favorable results are expected to significantly improve the treatment of PE.
Inari Medical: Growth Set To Reaccelerate In The Back Half Of The Year
06:37pm, Wednesday, 07'th Sep 2022
Shares are down 25% year to date. Covid limited Inari's ability to develop the DVT market, so a post-pandemic constructive hospital environment provides them a nice tailwind going forward.
Here's Why You Should Retain Inari Medical (NARI) Stock Now
01:32pm, Monday, 29'th Aug 2022
Inari Medical (NARI) continues to benefit from its commitment to understanding the venous system. However, dependency on the wide adoption of products is a woe.
Inari Medical to Present at Upcoming Investor Conferences
04:36pm, Thursday, 25'th Aug 2022
IRVINE, Calif., Aug. 25, 2022 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from
Inari Medical (NARI) Q2 Earnings Beat, CEO Transition in 2023
11:18am, Thursday, 04'th Aug 2022
Inari Medical's (NARI) second-quarter results benefit from significant progress made across all its growth drivers.
Inari Medical, Inc. (NARI) CEO Bill Hoffman on Q2 2022 Results - Earnings Call Transcript
11:18pm, Wednesday, 03'rd Aug 2022
Inari Medical, Inc. (NASDAQ:NARI ) Q2 2022 Earnings Conference Call August 3, 2022 5:00 PM ET Company Participants Caroline Corner - IR Bill Hoffman - President and CEO Mitch Hill - CFO Drew Hykes - C
Inari Medical: Fundamentals Soft, Technicals Supportive Of Near-Term Upside Capture
12:23pm, Friday, 22'nd Jul 2022
Inari Medical has curled up since May, with the share catching a bid and strengthening against key benchmarks. It has exposure to key alternative premia currently driving equity markets in FY22.
Inari Medical to Announce Second Quarter 2022 Financial Results
04:01pm, Monday, 18'th Jul 2022
IRVINE, Calif., July 18, 2022 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from
Have $500 to Spare? Buy These 2 Top Stocks Now for 10X Gains
05:13am, Saturday, 25'th Jun 2022
These beaten-down stocks are poised to deliver enormous gains for patient investors.
Here's Why You Should Retain Inari Medical (NARI) Stock Now
09:17am, Wednesday, 22'nd Jun 2022
Inari Medical (NARI) continues to benefit from its commitment toward understanding the venous system. However, dependency on the wide adoption of products is a woe.
Inari Medical Announces Launch of 2021 Ethos and Sustainability Report
08:01pm, Friday, 13'th May 2022 GlobeNewswire Inc.
IRVINE, Calif., May 13, 2022 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from
Inari Medical (NARI) Down 16.9% Despite Q1 Earnings Beat
04:16pm, Friday, 06'th May 2022 Zacks Investment Research
Inari Medical's (NARI) first-quarter results benefit from significant progress made across all of its growth drivers.
Inari Medical (NARI) Down 16.9% Despite Q1 Earnings Beat
01:33pm, Friday, 06'th May 2022
Inari Medical's (NARI) first-quarter results benefit from significant progress made across all of its growth drivers.
Inari Medical, Inc. (NARI) CEO Bill Hoffman on Q1 2022 Results - Earnings Call Transcript
10:40am, Thursday, 05'th May 2022
Inari Medical, Inc. (NASDAQ:NARI ) Q1 2022 Earnings Conference Call May 4, 2022 4:30 PM ET Company Participants Caroline Corner - IR Bill Hoffman - CEO Mitch Hill - CFO Drew Hykes - COO Tom Tu - CMO C
Inari Medical Q1 Earnings Beat Street View, Lifts FY22 Sales Outlook Above Consensus
10:07am, Thursday, 05'th May 2022
Inari Medical Inc's (NASDAQ: NARI) Q1 revenue was $86.8 million, up 4% sequentially and 51% Y/Y, beating the consensus of $83.61 million. The increase over the prior year was driven by continued U.S
